As shown in Figure 1A, MRC2 is differentially expressed between tumor and normal tissues in 14 of 33 cancers (Highly expressed in CHOL, GBM, HNSC, and THCA, whereas lowly expressed in BLCA, CESC, KICH, KIRC, KIRP, LUAD, LUSC, PCPG, PRAD, and UCEC). The gene discussed is MRC2; the disease is glioblastoma.